183 related articles for article (PubMed ID: 34738234)
21. Minimal interleukin 6 (IL-6) receptor stalk composition for IL-6 receptor shedding and IL-6 classic signaling.
Baran P; Nitz R; Grötzinger J; Scheller J; Garbers C
J Biol Chem; 2013 May; 288(21):14756-68. PubMed ID: 23564454
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-6 trans-signalling in chronic inflammation and cancer.
Scheller J; Ohnesorge N; Rose-John S
Scand J Immunol; 2006 May; 63(5):321-9. PubMed ID: 16640655
[TBL] [Abstract][Full Text] [Related]
23. sIL-6R: more than an agonist?
Knüpfer H; Preiss R
Immunol Cell Biol; 2008 Jan; 86(1):87-91. PubMed ID: 17724457
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of interleukin-6-transsignaling via gp130-Fc in hemorrhagic shock and sepsis.
Mees ST; Toellner S; Marx K; Faendrich F; Kallen KJ; Schroeder J; Haier J; Kahlke V
J Surg Res; 2009 Dec; 157(2):235-42. PubMed ID: 19589542
[TBL] [Abstract][Full Text] [Related]
25. Structure-guided optimization of the interleukin-6 trans-signaling antagonist sgp130.
Tenhumberg S; Waetzig GH; Chalaris A; Rabe B; Seegert D; Scheller J; Rose-John S; Grötzinger J
J Biol Chem; 2008 Oct; 283(40):27200-7. PubMed ID: 18650419
[TBL] [Abstract][Full Text] [Related]
26. An interleukin-6 receptor-dependent molecular switch mediates signal transduction of the IL-27 cytokine subunit p28 (IL-30) via a gp130 protein receptor homodimer.
Garbers C; Spudy B; Aparicio-Siegmund S; Waetzig GH; Sommer J; Hölscher C; Rose-John S; Grötzinger J; Lorenzen I; Scheller J
J Biol Chem; 2013 Feb; 288(6):4346-54. PubMed ID: 23209286
[TBL] [Abstract][Full Text] [Related]
27. The role of the interleukin (IL)-6/IL-6 receptor axis in cancer.
Taher MY; Davies DM; Maher J
Biochem Soc Trans; 2018 Dec; 46(6):1449-1462. PubMed ID: 30467123
[TBL] [Abstract][Full Text] [Related]
28. IL-6 controls the innate immune response against Listeria monocytogenes via classical IL-6 signaling.
Hoge J; Yan I; Jänner N; Schumacher V; Chalaris A; Steinmetz OM; Engel DR; Scheller J; Rose-John S; Mittrücker HW
J Immunol; 2013 Jan; 190(2):703-11. PubMed ID: 23241882
[TBL] [Abstract][Full Text] [Related]
29. Increased IL-6 and Potential IL-6 trans-signalling in the airways after an allergen challenge.
Esnault S; Khosravi M; Kelly EA; Liu LY; Bochkov YA; Tattersall MC; Jarjour NN
Clin Exp Allergy; 2021 Apr; 51(4):564-573. PubMed ID: 33471392
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-6: A Masterplayer in the Cytokine Network.
Uciechowski P; Dempke WCM
Oncology; 2020; 98(3):131-137. PubMed ID: 31958792
[TBL] [Abstract][Full Text] [Related]
31. Different Soluble Forms of the Interleukin-6 Family Signal Transducer gp130 Fine-tune the Blockade of Interleukin-6 Trans-signaling.
Wolf J; Waetzig GH; Chalaris A; Reinheimer TM; Wege H; Rose-John S; Garbers C
J Biol Chem; 2016 Jul; 291(31):16186-96. PubMed ID: 27226573
[TBL] [Abstract][Full Text] [Related]
32. Molecular and functional characterization of IL-6 receptor (IL-6R) and glycoprotein 130 (gp130) in Nile tilapia (Oreochromis niloticus).
Zhou E; Yan F; Li B; Chen M; Tu X; Wu S; Wu H; Wei X; Fu S; Wu L; Guo Z; Ye J
Dev Comp Immunol; 2020 May; 106():103629. PubMed ID: 31987875
[TBL] [Abstract][Full Text] [Related]
33. Soluble interleukin-6 receptor (sIL-6R) makes IL-6R negative T cell line respond to IL-6; it inhibits TNF production.
Igaz P; Horváth A; Horváth B; Szalai C; Pállinger E; Rajnavölgyi E; Tóth S; Rose-John S; Falus A
Immunol Lett; 2000 Mar; 71(3):143-8. PubMed ID: 10722865
[TBL] [Abstract][Full Text] [Related]
34. IL-6/IL-6 receptor system and its role in physiological and pathological conditions.
Mihara M; Hashizume M; Yoshida H; Suzuki M; Shiina M
Clin Sci (Lond); 2012 Feb; 122(4):143-59. PubMed ID: 22029668
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of cilia-localized Il-6R alpha by 17beta-estradiol in mouse and human fallopian tubes.
Shao R; Nutu M; Karlsson-Lindahl L; Benrick A; Weijdegård B; Lager S; Egecioglu E; Fernandez-Rodriguez J; Gemzell-Danielsson K; Ohlsson C; Jansson JO; Billig H
Am J Physiol Cell Physiol; 2009 Jul; 297(1):C140-51. PubMed ID: 19420002
[TBL] [Abstract][Full Text] [Related]
36. Activation of gp130 by IL-6/soluble IL-6 receptor induces neuronal differentiation.
März P; Herget T; Lang E; Otten U; Rose-John S
Eur J Neurosci; 1997 Dec; 9(12):2765-73. PubMed ID: 9517481
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic targeting of IL-6 trans-signaling.
Rose-John S
Cytokine; 2021 Aug; 144():155577. PubMed ID: 34022535
[TBL] [Abstract][Full Text] [Related]
38. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses.
Jostock T; Müllberg J; Ozbek S; Atreya R; Blinn G; Voltz N; Fischer M; Neurath MF; Rose-John S
Eur J Biochem; 2001 Jan; 268(1):160-7. PubMed ID: 11121117
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-6: from basic biology to selective blockade of pro-inflammatory activities.
Scheller J; Garbers C; Rose-John S
Semin Immunol; 2014 Feb; 26(1):2-12. PubMed ID: 24325804
[TBL] [Abstract][Full Text] [Related]
40. The regenerative activity of interleukin-6.
Galun E; Rose-John S
Methods Mol Biol; 2013; 982():59-77. PubMed ID: 23456862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
